Stockreport

BriaCell Selected to Present Phase 2 & 3 Clinical Data at SABCS® 2025

BriaCell Therapeutics Corp. - Common Shares  (BCTX) 
PDF Three BriaCell poster presentations include updated key biomarker data from BriaCell’s pivotal Phase 3 study and updated survival data from the Phase 2 study of Bria-IMT [Read more]